LOGO
LOGO

Entertainment News

Green Day Earn Seventh No. 1 On Billboard's Rock & Alternative Airplay Chart

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us

Green Day have earned their seventh leader on Billboard's Rock & Alternative Airplay Chart thanks to "The American Dream Is Killing Me" rising from No. 2 to No. 1 on the November 18-dated list.

The song has made it to the top of the list in its third week, registering a 10% surge in audience impressions to 9.5 million in the tracking week ended November 9, according to Luminate.

The song's rise to the top on Rock & Alternative Airplay is the quickest since Linkin Park's "Lost" debuted atop the February 25-dated ranking. It's Green Day's fastest since "Oh Love" launched at No. 1 in August 2012.

Green Day had last led Rock & Alternative Airplay with "Oh Yeah!" a two-week No. 1 in April 2020.

Most No. 1s, Rock & Alternative Airplay:

11, Foo Fighters
7, Green Day
6, Cage the Elephant
6, twenty one pilots
5, The Black Keys
5, Imagine Dragons
4, Linkin Park
4, Red Hot Chili Peppers
3, Weezer

"The American Dream Is Killing Me" is at No. 2 on Alternative Airplay and at No. 3 on Mainstream Rock Airplay. On Adult Alternative Airplay, the song has advanced to No. 21.

"The American Dream Is Killing Me" is the lead single from Green Day's upcoming 14th studio album Saviors, which is due January 19, 2024.

(Photo: Pamela Littky)

For comments and feedback contact: editorial@rttnews.com

Entertainment News

Global Economics Weekly Update: May 11 – May 15, 2026

May 15, 2026 15:25 ET
Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.

Latest Updates on COVID-19